Fact CheckerSign in

NCT06907693Completed

The Effects of Drug Candidate CS1 on Lung Structure and Function Utilizing FRI

The Effects of Drug Candidate CS1 on Lung Structure and Function Utilizing FRI, a Non-Invasive, Functional Respiratory Imaging System

Source: ClinicalTrials.gov · Last updated 13 Apr 2026

Brief summary (registry, in English)

Explore the impact of drug candidate CS1 on pathological vascular remodeling of small pulmonary arteries in the disease pulmonary arterial hypertension (PAH). This sub-study for CS1-004 aims to utilize FRI, an innovative, non-invasive imaging technology to visualize how long-term use of CS1 influences structural changes in pulmonary arteries. This sub-study seeks to provide valuable insights into the potential of CS1 to transform PAH treatment in some patients enrolled in the Expanded Access Program (CS1-004).

Status (registry)
Completed
Study type
Observational
Enrollment
7 (actual)
First submitted
27 Mar 2025
Start date
Mar 2025
Primary completion date
Dec 2025
Lead sponsor
Prisma Health-Upstate
NCT number
NCT06907693

What you commit to

  • Study type: Observational
  • Participants enrolled: 7
  • From Mar 2025 to the primary completion date, Dec 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Allergy to Iodine contrast agents

Lab values

  • eGFR \<30 mL/min/1.73m2 as calculated by Modification of Diet in Renal Disease (MDRD)

Other

  • Inability to undergo a CT pulmonary angiography scan (i.e., claustrophobia)
  • Individuals who are pregnant or who become pregnant during the sub-study

Who the study is looking for

  • Participation in the CS1-004 clinical trial

Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Prisma Health
Coordinator of this site? Confirm its status
GreenvilleUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.